Local News

Tranzyme Names Executive For Business Development

Posted August 11, 2006 8:07 a.m. EDT

— Eric Nelson, a 20-year veteran of the life science industry, is the new vice president for business development and licensing at

Tranzyme Pharma

.

Tranzyme is focused on drugs to treat gastrointestinal and metabolic diseases.

Nelson's most recent position was as assistant vice president for technology licensing at Wyeth-Ayerst Laboratories. He earlier had worked as director of business development at Becton Dickinson.